Products description
Untitled 1
KeraPhine Body Smoothing Lotion
We are very excited to introduce Obagi's newest and first-ever body product:
KèraPhine Body Smoothing Lotion - a solution to help smooth rough and bumpy
skin.
KèraPhine is formulated with rich emollients and these powerful exfoliants: 15%
glycolic acid and 5% ammonium lactate.
With daily use, KèraPhine helps to restore healthy-looking skin, and in as early
as 4 weeks, this body smoothing lotion is clinically proven to:
- Exfoliate and remove dead skin cells from the surface of the skin
- Help smooth rough and bumpy skin on the arms and legs
- Reduce dryness on the arms
Direction
Untitled 2
apply to affected area(s) once daily or as directed by your physician.
Before and After using Obagi
Nu-Derm System Treatment Beautiful skin is healthy skin. It is firm and smooth, with even skin tone
and glowing color. It is free from medical problems and it is normal in function
and tolerance. We are born with healthy skin, but time, the sun, and
environmental assaults take their toll.
Your
personal skin health
program...
The Obagi System recognizes that your skin is a living organ with
interacting functions. Restoring the health of your skin cannot happen if you
merely treat the symptoms. To achieve (and maintain) skin health, you must
correct the underlying problems and stimulate the growth of new, radiant,
healthy skin cells. The Obagi Nu-Derm System meets this challenge with a daily
program of five easy steps.
**Important
The Obagi Nu Derm System is prescribed only by physicians who
are trained in the use and monitoring of the program. Prior to ordering any of
these products, you must have completed our Skin care questionnaire
and the physician''s response analysis must be on file here at physicians Skin
Attraction Inc.
Please click the links below to open or download the forms. After filling out
the forms, please email or fax them back to us. Thank You!
1.
Patient Information
2.
Patient skin history & analysis
3.
Patient consent for use of skin corrective creams